Virax Biolabs
VRAX
VRAX
4 hedge funds and large institutions have $195K invested in Virax Biolabs in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$178K |
| 2 |
VF
2
Virtu Financial
New York
|
$16K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$971 |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $178K | 121,999 | +121,999 | New |
|
|
VF
2
Virtu Financial
New York
| $16K | 10,644 | +10,644 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $971 | 665 | +518 | +352% |
|
4
Wells Fargo
San Francisco,
California
| $292 | 200 | -1,800 | -90% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | – | -16,362 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -15,000 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|